HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aurélien Lebreton Selected Research

Acquired Protein C Deficiency

4/2017Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aurélien Lebreton Research Topics

Disease

6Hemorrhage
03/2021 - 01/2015
4Fibrosis (Cirrhosis)
09/2020 - 03/2016
4Thrombocytopenia (Thrombopenia)
07/2020 - 01/2013
3Thrombophilia
09/2020 - 04/2017
2Venous Thromboembolism
01/2022 - 06/2019
2Hemophilia A (Haemophilia)
03/2021 - 11/2011
2Thrombosis (Thrombus)
01/2021 - 02/2015
1Hemolysis
01/2022
1Jaundice (Icterus)
01/2022
1Hyperlipidemias (Hyperlipidemia)
01/2022
1Activated Protein C Resistance (APC Resistance)
10/2021
1COVID-19
01/2021
1Intracranial Sinus Thrombosis (Sinus Thrombosis)
01/2021
1Angiodysplasia
01/2021
1Malnutrition (Nutritional Deficiencies)
01/2021
1Protein C Deficiency
09/2020
1Hemophilia B (Haemophilia B)
05/2020
1Thromboembolism
01/2020
1Cardiovascular Diseases (Cardiovascular Disease)
11/2019
1Acquired Protein S Deficiency
04/2017
1Acquired Protein C Deficiency
04/2017
1Afibrinogenemia (Fibrinogen Deficiency)
08/2016
1Subdural Hematoma (Subdural Hemorrhage)
06/2015
1Cerebral Hemorrhage
06/2015
1Necrosis
01/2013

Drug/Important Bio-Agent (IBA)

5ThrombinFDA Link
10/2021 - 06/2015
4Heparin (Liquaemin)FDA LinkGeneric
07/2020 - 01/2013
3AnticoagulantsIBA
03/2021 - 11/2019
2Protein CIBA
10/2021 - 04/2017
2Hemostatics (Antihemorrhagics)IBA
03/2021 - 03/2016
2AntigensIBA
01/2021 - 01/2015
2ThrombomodulinIBA
01/2020 - 04/2017
2Fibrinogen (Factor I)FDA Link
08/2016 - 01/2015
1BilirubinIBA
01/2022
1fibrin fragment D (D-dimer)IBA
01/2022
1AntibodiesIBA
01/2022
1Rheumatoid FactorIBA
01/2022
1Hemoglobins (Hemoglobin)IBA
01/2022
1phospholipid emulsion soybean oil (Intralipid)IBA
01/2022
1Contraceptive Agents (Contraceptives)IBA
10/2021
1SteroidsIBA
10/2021
1Blood Coagulation Factors (Coagulation Factor)IBA
03/2021
1ChAdOx1 nCoV-19IBA
01/2021
1Capsules (Microcapsules)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1VaccinesIBA
01/2021
1Vitamin KFDA Link
01/2021
1ZincIBA
01/2021
1AntithrombinsIBA
09/2020
1factor IX Fc fusion proteinIBA
05/2020
1idarucizumabIBA
01/2020
1DabigatranFDA Link
01/2020
1Catechin (Z 7300)IBA
11/2019
1A-factor (Streptomyces)IBA
06/2019
1edoxabanIBA
06/2019
1RivaroxabanIBA
06/2015
1Prothrombin (Factor II)IBA
06/2015
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2013
1IsoantibodiesIBA
11/2011
1Factor VIII (Coagulation Factor VIII)IBA
11/2011
1AutoantibodiesIBA
11/2011

Therapy/Procedure

2Therapeutics
03/2021 - 01/2021
2Operative Surgical Procedures
01/2020 - 01/2015
1Argon Plasma Coagulation
01/2021
1Anticoagulation Reversal
06/2015
1Hemofiltration
02/2015